Someone walks into a clinic with a persistent cough. Perhaps they have been losing weight, waking up with night sweats or feeling unwell for weeks.They may have tuberculosis. But will they be tested?That simple question matters enormously in South Africa, where TB...
CATHCA Updates: September 2026 Spring Edition The Spring Edition of CATHCA Updates shares some of the latest activities, initiatives and developments taking place across the CATHCA network. Under the theme “A Season of Renewal: Bringing Hope, Healing and Compassion to...
CATHCA joined healthcare professionals and other stakeholders for an informative webinar organised by South Africa’s National Department of Health, focusing on the prevention, early identification and management of Foetal Alcohol Spectrum Disorder (FASD). The session...
That is what lenacapavir offers. It is one of the most exciting developments in HIV prevention in recent years, particularly in Southern Africa, where HIV continues to affect millions of people and places a heavy burden on families and communities. And people clearly...
CATHCA is pleased to share two information posters on Lenacapavir, a long-acting HIV prevention option administered twice a year.The first poster is a practical fact sheet explaining what Lenacapavir is, its benefits and its role in HIV prevention. The second reflects...
CATHCA CALLS FOR THE PROTECTION OF VULNERABLE COMMUNITIES AS HIV AND TB FUNDING DECLINES – SACBC As South Africa prepares for a future with reduced international support for HIV and tuberculosis (TB) programmes, health advocates are calling for a careful and...
